322 (Memantine Hydrochloride 10 mg)
Pill with imprint 322 is Gray, Capsule-shape and has been identified as Memantine Hydrochloride 10 mg. It is supplied by Sun Pharmaceutical Industries.
Memantine is used in the treatment of alzheimer's disease; migraine; autism and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 322
Memantine Hydrochloride
- Imprint:
- 322
- Strength:
- 10 mg
- Color:
- Gray
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous central nervous system agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Sun Pharmaceutical Industries
- National Drug Code (NDC):
- 47335-0322
More about memantine
- Memantine Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 37 Reviews
- Drug class: miscellaneous central nervous system agents
Consumer resources
- Memantine
- Memantine Tablets
- Memantine Extended-Release Capsules
- Memantine Solution
- Memantine (Advanced Reading)
Other brands: Namenda, Namenda XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
